IGYXOS
Igyxos’ mission is to develop innovative new pharmaceuticals and medical technologies in the field of human fertility. Igyxos is involved in all phases of development, from the discovery of promising targets to the identification of potential lead compounds such as small molecules and antibodies, and the acquisition of intellectual property rights to drugs and technologies that can then be brought to the development phase. Igyxos also support the transfer of potential drug candidates to pre-clinical and clinical phases of drug development.
IGYXOS
Social Links:
Industry:
Biotechnology Pharmaceutical
Founded:
2017-01-01
Address:
Nouzilly, Centre, France
Country:
France
Website Url:
http://www.igyxos.com
Total Employee:
1+
Status:
Active
Contact:
+ 33 2 47 42 79 57
Email Addresses:
[email protected]
Total Funding:
7.5 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Google Apps For Business Google GStatic Google Static Content
Similar Organizations
Allcyte
Allcyte is a biotech start-up focused on precision medicine and drug development in a patient-centric way using high-content imaging and AI
Current Employees Featured
Founder
Investors List
GO CAPITAL
GO CAPITAL investment in Series A - Igyxos
Bpifrance
Bpifrance investment in Series A - Igyxos
Sofimac Innovation
Sofimac Innovation investment in Series A - Igyxos
Official Site Inspections
http://www.igyxos.com Semrush global rank: 5.93 M Semrush visits lastest month: 1.39 K
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Igyxos" on Search Engine
Igyxos - Crunchbase Company Profile & Funding
Operating Status Active. Last Funding Type Series A. Legal Name IGYXOS S.A. Company Type For Profit. Contact Email [email protected]. Phone Number + 33 2 47 42 79 57. …See details»
Igyxos Company Profile - Office Locations, Competitors, …
Igyxos is a biotech startup developing pharmaceuticals and medical technologies in the field of human fertility.See details»
Igyxos and Selexis Enter Service Agreement to Advance Igyxos’ …
Sep 2, 2020 Geneva, Switzerland, and Nouzilly, France - September 2, 2020 - Selexis SA and Igyxos announced today that they have entered into a service agreement to …See details»
Igyxos and Selexis Enter Service Agreement to Advance …
Sep 2, 2020 Igyxos’ mission is to develop new and innovative medical and pharmaceutical technologies in the field of human fertility. Igyxos is involved in all …See details»
French biotech startup Igyxos raises €7.5 million …
Mar 21, 2019 French biotech startup Igyxos raises €7.5 million Series A to develop a new treatment for infertility. By Mary Loritz. March 21, 2019. Infertility affects about 70 million women and 30 million men worldwide, …See details»
Igyxos on LinkedIn: Igyxos Initiates Phase 1 Clinical …
Igyxos, a leading biopharmaceutical company specializing in infertility solutions, is thrilled to announce the dosing of the first healthy volunteer in the First in Human (FIH) Phase 1 …See details»
Thierry Ziegler - Chief Operating Officer at Igyxos
Thierry Ziegler. Chief Operating Officer at Igyxos. Show contact. Thierry Ziegler has more than 25 years of experience in biopharmaceutical development. Prior to joining Igyxos, he led cell therapy production …See details»
Igyxos - Funding, Financials, Valuation & Investors - Crunchbase
Igyxos is a biotech startup developing a new treatment for female and male infertility that works by shifting hormal imbalances.See details»
Latest News | Igyxos Biotherapeutics
2022. 21. Igyxos pursues its development and appoints Thierry Ziegler as CMC Chief Operating Officer. MAR15. 2021. 20. Igyxos and Selexis enter service agreement to …See details»
Igyxos Initiates Phase 1 Clinical Trials for IGX12: A Breakthrough ...
PARIS, FRANCE, November 3, 2023 / EINPresswire.com / -- Igyxos, a leading biopharmaceutical company specializing in infertility solutions, is thrilled to announce the …See details»
Igyxos - Contacts, Employees, Board Members, Advisors
Igyxos is a biotech startup developing a new treatment for female and male infertility that works by shifting hormal imbalances.See details»
Igyxos | VentureRadar
Igyxos, a French biotechnology company is developing IGX12, a First-In-Class treatment for female and male infertility; based on an innovative proprietary technology dedicated …See details»
Igyxos and Selexis Enter Service Agreement to Advance Igyxos’ …
Sep 2, 2020 Igyxos’ mission is to develop new and innovative medical and pharmaceutical technologies in the field of human fertility. Igyxos is involved in all …See details»
Igyxos and Selexis Enter Service Agreement to Advance Igyxos …
Sep 2, 2020 Igyxos’ mission is to develop new and innovative medical and pharmaceutical technologies in the field of human fertility. Igyxos is involved in all …See details»
Igyxos and Selexis Enter Service Agreement to Advance Igyxos’ …
On Sep 3, 2020. Selexis SA and Igyxos announced that they have entered into a service agreement to develop Igyxos’ first-in-class monoclonal antibody (mAb) drug candidate …See details»
Infertility Overview | Igyxos Biotherapeutics
Overview. Infertility in Women. Infertility in Men. GLOBAL PATIENT NEED FOR NEW MEDICAL OPTIONS FOR INFERTILTY. Infertility is a disease of the male or female …See details»
Igyxos - Crunchbase
Organization. Igyxos. Connect to CRM. Summary Financials People Technology Signals & News Similar Companies. Similar Companies. Powered by AI. Companies like Igyxos …See details»
Igyxos - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Organization. Igyxos. Connect to CRM. Summary Financials People Technology Signals & News Similar Companies. Highlights. Active Tech Count 29. About. Igyxos is actively …See details»